Somerville, MA, United States of America

James Bourassa

USPTO Granted Patents = 26 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 113(Granted Patents)

Company Filing History:

21 out of 3,682

The Johns Hopkins University

patents

7 out of 53

Kala Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12178920 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2024-12-31),

2. 12115246 - Compositions and methods for ophthalmic and/or other applications (2024-10-15),

3. 11872318 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2024-01-16),

4. 11642317 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2023-05-09),

5. 11596599 - Compositions and methods for ophthalmic and/or other applications (2023-03-07),

6. 11219597 - Compositions and methods for ophthalmic and/or other applications (2022-01-11),

7. 11219596 - Compositions and methods for ophthalmic and/or other applications (2022-01-11),

8. 11091487 - Meropenem derivatives and uses thereof (2021-08-17),

9. 10993908 - Compositions and methods for ophthalmic and/or other applications (2021-05-04),

10. 10945948 - Compositions and methods for ophthalmic and/or other applications (2021-03-16),

11. 10940108 - Compositions and methods for ophthalmic and/or other applications (2021-03-09),

12. 10864219 - Compositions and methods for ophthalmic and/or other applications (2020-12-15),

13. 10857096 - Compositions and methods for ophthalmic and/or other applications (2020-12-08),

14. 10736854 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2020-08-11),

15. 10688045 - Compositions and methods for ophthalmic and/or other applications (2020-06-23),

Title: James Bourassa: Pioneering Innovations in Nanocrystals for Enhanced Drug Delivery

Introduction:

James Bourassa, a prolific inventor based in Somerville, MA, is a visionary in the field of nanotechnology, with a remarkable portfolio of 24 patents. His relentless pursuit of innovation and commitment to pushing the boundaries of technology have solidified his position as a true pioneer in the world of inventions.

Latest Patents:

Among his latest patents is the groundbreaking work on Nanocrystals, compositions, and methods that aid particle transport in mucus. These innovative compositions and methods involve the development of mucus-penetrating particles (MPP) to enhance the transport of pharmaceutical agents through mucus barriers in the body. This advancement holds tremendous potential for revolutionizing drug delivery, imaging, and diagnostic applications.

Career Highlights:

Throughout his illustrious career, James Bourassa has been associated with esteemed institutions like The Johns Hopkins University and Kala Pharmaceuticals, Inc. His dedication to research and development has led to the creation of cutting-edge technologies that have the power to transform the healthcare industry as we know it.

Collaborations:

James Bourassa has collaborated closely with talented individuals in his field, including colleagues like Alexey Popov and Elizabeth M Enlow. These partnerships have been instrumental in driving innovation forward and bringing revolutionary ideas to life.

Conclusion:

James Bourassa's innovative spirit and groundbreaking contributions to nanocrystals and drug delivery technology continue to inspire the next generation of inventors. His work not only shapes the future of technology but also paves the way for a new era of advancements in healthcare. James Bourassa is a true luminary in the world of inventions, and his legacy will undoubtedly endure for years to come.

This text is generated by artificial intelligence and may not be accurate.